NEJM study shows CRISPR therapy results in children ages 5-11
Go back to NEJM study shows CRISPR therapy results in children ages 5-11| HCA HOLDINGS, Inc. (NYSE: HCA) | Delayed: 427.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $427.71 | 52 Week High | $83.69 | |||
| Open | $427.71 | 52 Week Low | $60.07 | |||
| Day High | $427.71 | P/E | 126.92 | |||
| Day Low | $427.71 | EPS | $3.37 | |||
| Volume | 5 | |||||
